RCKTROCKET PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of ROCKET PHARMACEUTICALS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RCKTThis | $269M#6 | — | 0.7x#2 | — | — | 13.8%#5 | — | -60.5%#9 | — | — | -31.2%#6 | — |
| BNTC | $296M#1 | — | 1.7x#6 | — | -100.0%#7 | -20.6%#8 | — | -25.8%#4 | — | — | -46.6%#7 | — |
| MPLT | $292M#2 | 0.1x#1 | 0.8x#3 | — | — | -107.7%#12 | — | -46.3%#7 | — | — | -58.7%#9 | — |
| LYEL | $279M#3 | — | 1.2x#4 | 7742.9x#8 | -41.0%#5 | 20.0%#3 | -748344.4%#9 | -117.4%#10 | — | — | -30.6%#5 | — |
| CYPH | $277M#4 | 4.0x#3 | 2.0x#8 | 184.6x#7 | 0.0%#4 | 107.4%#2 | -2737.8%#8 | 3.6%#2 | — | — | 519.1%#1 | — |
| BIOA | $272M#5 | — | 0.7x#1 | 30.3x#4 | — | -13.4%#7 | -1031.5%#5 | -21.5%#3 | — | — | -20.1%#4 | — |
| ARCT | $263M#7 | — | 1.5x#5 | 3.2x#2 | -46.1%#6 | 18.7%#4 | -93.0%#3 | -38.3%#5 | -136.2%#3 | — | -0.3%#3 | — |
| LRMR | $261M#8 | — | 2.0x#9 | — | — | -105.5%#11 | — | -130.1%#11 | -350.3%#4 | — | — | — |
| QTTB | $260M#9 | 2.8x#2 | 2.5x#10 | 4.8x#3 | — | 162.5%#1 | 31.5%#1 | 28.1%#1 | — | — | 240.3%#2 | — |
| BCYC | — | — | — | — | 105.8%#2 | -29.5%#9 | -340.4%#4 | -43.3%#6 | -372.9%#5 | — | -49.7%#8 | — |
| GLSI | $253M#10 | — | 81.0x#11 | — | — | -11.2%#6 | — | -621.1%#12 | — | — | — | — |
| CAMP | $245M#11 | — | — | 70.1x#6 | 436.5%#1 | -55.2%#10 | -1502.4%#6 | — | — | — | — | — |
| ABEO | $244M#12 | — | 1.9x#7 | 41.9x#5 | — | -211.7%#13 | -1536.9%#7 | -55.6%#8 | -121.6%#2 | — | — | — |
| LFCR | $243M#13 | — | — | 1.9x#1 | 0.5%#3 | -422.5%#14 | -13.4%#2 | — | -28.7%#1 | 3#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice